Loading…
CIK 0001848809 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("velan-capital-investment-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $9.0M | 5.2%Prev: 5.1% | 67,000 SH | Increased+2,611 SH |
| ARROWHEAD PHARMACEUTICALS IN | COM | $432K | 0.3%Prev: 0.2% | 6,500 SH | Increased |
| AVALO THERAPEUTICS INC | COM NEW | $4.8M | 2.8%Prev: 3.1% | 263,642 SH | Increased |
| CIDARA THERAPEUTICS INC | COM NEW | $23.9M | 13.9%Prev: 9.8% | 108,404 SH | Increased |
| CONTEXT THERAPEUTICS INC | COM | $147K | 0.1%Prev: 0.1% | 100,000 SH | Increased |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $106K | 0.1%Prev: 0.7% | 13,000 SH | Decreased-48,000 SH |
| CYTOMX THERAPEUTICS INC | COM | $341K | 0.2%Prev: 0.2% | 80,000 SH | Increased |
| DESIGN THERAPEUTICS INC | COM | $188K | 0.1%Prev: 0.1% | 20,000 SH | Increased |
| EDESA BIOTECH INC | COM NEW | $976K | 0.6%Prev: 1.6% | 687,500 SH | Decreased |
| ESPERION THERAPEUTICS INC NE | COM | $4.5M | 2.6% | 1,210,000 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $2.7M | 1.5%Prev: 2.0% | 352,000 SH | Increased |
| EVOMMUNE INC | COM SHS | $8.7M | 5.0% | 506,754 SH | New |
| GOSSAMER BIO INC | COM | $217K | 0.1%Prev: 0.2% | 70,000 SH | Increased |
| HERON THERAPEUTICS INC | COM | $11.4M | 6.6%Prev: 10.4% | 8,753,290 SH | Increased |
| IMMIX BIOPHARMA INC | COM | $183K | 0.1%Prev: 0.1% | 35,000 SH | Increased |
| IMMUNOME INC | COM | $215K | 0.1%Prev: 0.1% | 10,000 SH | Increased |
| INSPIREMD INC | COM | $3.8M | 2.2%Prev: 4.9% | 2,143,698 SH | Decreased |
| JASPER THERAPEUTICS INC | COM NEW | $4.9M | 2.8%Prev: 5.8% | 2,668,395 SH | Decreased |
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | $2.1M | 1.2% | 300,000 SH | New |
| LANTHEUS HLDGS INC | COM | $5.0M | 2.9%Prev: 3.5% | 74,687 SH | Increased+1,142 SH |
| LARIMAR THERAPEUTICS INC | COM | $126K | 0.1%Prev: 0.1% | 33,000 SH | Increased |
| MAPLIGHT THERAPEUTICS INC | COM | $9.2M | 5.3% | 522,305 SH | New |
| MINERALYS THERAPEUTICS INC | COM | $5.5M | 3.2%Prev: 6.3% | 151,000 SH | Decreased-24,600 SH |
| NURIX THERAPEUTICS INC | COM | $304K | 0.2%Prev: 0.1% | 16,000 SH | Increased |
| OVID THERAPEUTICS INC | COM | $261K | 0.2%Prev: 0.2% | 160,000 SH | Increased |
| PMV PHARMACEUTICALS INC | COM | $44K | 0.0%Prev: 0.0% | 35,000 SH | Decreased |
| PRAXIS PRECISION MEDICINES I | COM NEW | $29.7M | 17.2%Prev: 6.6% | 100,781 SH | Increased-32,024 SH |
| PRECISION BIOSCIENCES INC | COM NEW | $83K | 0.0%Prev: 0.1% | 20,000 SH | Decreased |
| PROFOUND MED CORP | COM NEW | $2.2M | 1.3% | 285,710 SH | New |
| PROQR THRAPEUTICS N V | SHS EURO | $91K | 0.1%Prev: 0.1% | 45,000 SH | Decreased |
| PROTAGONIST THERAPEUTICS INC | COM | $323K | 0.2%Prev: 0.2% | 3,700 SH | Increased |
| PROTARA THERAPEUTICS INC | COM STK | $15.1M | 8.8%Prev: 8.7% | 2,834,652 SH | Increased+695,652 SH |
| PYXIS ONCOLOGY INC | COMMON STOCK | $46K | 0.0%Prev: 0.1% | 40,000 SH | Decreased-15,000 SH |
| RAPT THERAPEUTICS INC | COM NEW | $3.7M | 2.1%Prev: 1.9% | 108,000 SH | Increased+28,023 SH |
| REPLIMUNE GROUP INC | COM | $146K | 0.1%Prev: 0.1% | 15,000 SH | Increased-5,000 SH |
| REZOLUTE INC | COM NEW | $1.8M | 1.0%Prev: 6.6% | 750,000 SH | Decreased |
| SUTRO BIOPHARMA INC | COM SHS | $3.6M | 2.1% | 312,000 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $2.7M | 1.6%Prev: 1.9% | 130,000 SH | Increased |
| TENAX THERAPEUTICS INC | COM NEW | $1.0M | 0.6%Prev: 0.6% | 83,333 SH | Increased |
| TERNS PHARMACEUTICALS INC | COM | $2.8M | 1.6%Prev: 0.1% | 70,000 SH | Increased+50,000 SH |
| TREVI THERAPEUTICS INC | CALL | $482K | 0.3% | 38,500 SH | New |
| TREVI THERAPEUTICS INC | COM | $2.6M | 1.5%Prev: 1.8% | 205,000 SH | Increased |
| VENTYX BIOSCIENCES INC | COM | $361K | 0.2%Prev: 0.1% | 40,000 SH | Increased |
| VERRICA PHARMACEUTICALS INC | COM SHS | $3.9M | 2.3% | 471,559 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $2.7M | 1.6%Prev: 1.8% | 86,500 SH | Increased |
| XILIO THERAPEUTICS INC | COM | $109K | 0.1% | 170,000 SH | New |
| 13F-HR |
| 0001848809-26-000003 |
| $164.2M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001848809-25-000005 | $101.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001848809-26-000002 | $159.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000938552-25-000003 | $97.2M | View |